Form 8-K - Current report:
SEC Accession No. 0001387131-20-005991
Filing Date
2020-06-29
Accepted
2020-06-29 07:07:13
Documents
2
Period of Report
2020-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_062620.htm 8-K 31628
2 PRESS RELEASE OF THE COMPANY, DATED JUNE 29, 2020 ex99-01.htm EX-99.01 17285
  Complete submission text file 0001387131-20-005991.txt   50177
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 20995893
SIC: 2834 Pharmaceutical Preparations